Bayer Reports Significant Losses Amid Ongoing Glyphosate Challenges

The pharmaceutical and agribusiness giant struggles with legal battles, declining profits, and a challenging market outlook.

Bayer reported a net loss of €2.55 billion for 2024, driven by €5.5 billion in impairments, primarily in its agribusiness segment.
The company's operational profit (EBITDA) dropped 13.5% to €10.1 billion, with revenue declining slightly to €46.6 billion.
Over 60,000 lawsuits related to the herbicide glyphosate remain unresolved, with Bayer seeking regulatory clarity to mitigate legal risks.
CEO Bill Anderson has implemented cost-cutting measures, including eliminating 7,000 positions, and foresees recovery starting in 2026.
Challenges include falling crop protection prices, reduced demand in South America, and potential regulatory shifts under the new U.S. administration.